Comorbidity increases side effects of tyrosine kinase inhibitor in chronic myeloid leukemia.

AKINCI S., SILAY K., AKINCI M. B., ÖZTÜRK E., BAKANAY ÖZTÜRK Ş. M., DİLEK İ.

international journal of medical research and applications, 2017 (Hakemli Dergi)